Serum Albumin at Diagnosis is an Independent Predictor of Early Mortality in Veteran Patients with Esophageal Cancer

References

• Siegel RL, Miller KD, and Jemal A: Cancer statistics, 2018. CA Cancer J Clin 68(1), 7–30, 2018.
   PubMed Web of Science ®Google Scholar
• Martin IG, Young S, Sue-Ling H, and Johnston D: Delays in the diagnosis of oesophagogastric cancer: a consecutive case series. BMJ 314(7079), 467–470, 1997.
   PubMed Web of Science ®Google Scholar
• Howlader NNA, Krapcho M, Miller D, Bishop K, Kosary CL, et al. (eds.).: SEER Cancer Statistics Review, 1975-2014. https://seer.cancer.gov/csr/1975_2014/. 2017. Accessed September 24, 2017.
   Google Scholar
• Siddiqui A, Heinzerling J, Livingston EH, and Huerta S: Predictors of early mortality in veteran patients with pancreatic cancer. Am J Surg 194(3), 362–366, 2007.
   PubMed Web of Science ®Google Scholar
• Sohal DP, Shrotriya S, Glass KT, Pelley RJ, McNamara MJ, et al.: Predicting early mortality in resectable pancreatic adenocarcinoma: a cohort study. Cancer 121(11), 1779–1784, 2015.
   PubMed Web of Science ®Google Scholar
• Haj Mohammad N, Hulshof M, Bergman J, Geijsen D, Wilmink JW, et al.: Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma. BMC Cancer 14, 56, 2014.
   PubMed Web of Science ®Google Scholar
• Wikman A, Ljung R, Johar A, Hellstadius Y, Lagergren J, et al.: Psychiatric morbidity and survival after surgery for esophageal cancer: a population-based cohort study. J Clin Oncol 33(5), 448–454, 2015.
   PubMed Web of Science ®Google Scholar
• Stuschke M, Stahl M, Wilke H, Walz M, Oldenburg A, et al.: Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus. Am J Clin Oncol 23(3), 233–238, 2000.
   PubMed Web of Science ®Google Scholar
• Fanali G, di Masi A, Trezza V, Marino M, Fasano M, et al.: Human serum albumin: from bench to bedside. Mol Aspects Med 33(3), 209–290, 2012.
   PubMed Web of Science ®Google Scholar
• Gatta A, Verardo A, and Bolognesi M: Hypoalbuminemia. Intern Emerg Med 7 Suppl 3, S193–S199, 2012.
   PubMed Web of Science ®Google Scholar
• Merlot AM, Kalinowski DS, and Richardson DR: Unraveling the mysteries of serum albumin-more than just a serum protein. Front Physiol 5, 299, 2014.
   PubMed Web of Science ®Google Scholar
• McMillan DC: The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39(5), 534–540, 2013.
   PubMed Web of Science ®Google Scholar
• Di Fiore F, Lecleire S, Pop D, Rigal O, Hamidou H, et al.: Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 102(11), 2557–2563, 2007.
   PubMed Web of Science ®Google Scholar
• Wang CY, Hsieh MJ, Chiu YC, Li SH, Huang HW, et al.: Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy. Radiother Oncol 92(2), 270–275, 2009.
   PubMed Web of Science ®Google Scholar
• Douglas E and McMillan DC: Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score. Cancer Treat Rev 40(6), 685–691, 2014.
   PubMed Web of Science ®Google Scholar
• Aoyagi T, Terracina KP, Raza A, Matsubara H, and Takabe K: Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol 7(4), 17–29, 2015.
   PubMed Web of Science ®Google Scholar
• Lee JL, Oh ES, Lee RW, and Finucane TE: Serum albumin and prealbumin in calorically restricted, nondiseased individuals: a systematic review. Am J Med 128(9), 1023.e1021–1022, 2015.
   Web of Science ®Google Scholar
• Kratz F: Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 132(3), 171–183, 2008.
   PubMed Web of Science ®Google Scholar
• Gerndt SJ and Orringer MB: Tube jejunostomy as an adjunct to esophagectomy. Surgery 115(2), 164–169, 1994.
   PubMed Web of Science ®Google Scholar
• Jenkinson AD, Lim J, Agrawal N, and Menzies D: Laparoscopic feeding jejunostomy in esophagogastric cancer. Surg Endosc 21(2), 299–302, 2007.
   PubMed Web of Science ®Google Scholar
• Wani ML, Ahangar AG, Lone GN, Singh S, Dar AM, et al.: Feeding jejunostomy: does the benefit overweight the risk (a retrospective study from a single centre). Int J Surg 8(5), 387–390, 2010.
   PubMed Web of Science ®Google Scholar
• Ryan AM, Rowley SP, Healy LA, Flood PM, Ravi N, et al.: Post-oesophagectomy early enteral nutrition via a needle catheter jejunostomy: 8-year experience at a specialist unit. Clin Nutr 25(3), 386–393, 2006.
   PubMed Web of Science ®Google Scholar
• Baldwin C, Spiro A, Ahern R, and Emery PW: Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst 104(5), 371–385, 2012.
   PubMedGoogle Scholar
• Vlavianos P and Zabron A: Clinical outcomes, quality of life, advantages and disadvantages of metal stent placement in the upper gastrointestinal tract. Curr Opin Support Palliat Care 6(1), 27–32, 2012.
   PubMed Web of Science ®Google Scholar
• Dai Y, Li C, Xie Y, Liu X, Zhang J, et al.: Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev 10, CD005048, 2014.
   Google Scholar
• Knyrim K, Wagner HJ, Bethge N, Keymling M, and Vakil N: A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 329(18), 1302–1307, 1993.
   PubMed Web of Science ®Google Scholar
• Eickhoff A, Knoll M, Jakobs R, Weickert U, Hartmann D, et al.: Self-expanding metal stents versus plastic prostheses in the palliation of malignant dysphagia: long-term outcome of 153 consecutive patients. J Clin Gastroenterol 39(10), 877–885, 2005.
   PubMed Web of Science ®Google Scholar